Ignite Creation Date:
2025-12-24 @ 6:32 PM
Ignite Modification Date:
2025-12-25 @ 4:02 PM
Study NCT ID:
NCT01614457
Status:
COMPLETED
Last Update Posted:
2015-02-12
First Post:
2012-06-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT)
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07
Start Date Type:
None
Primary Completion Date:
2013-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-10
Completion Date Type:
ACTUAL
First Submit Date:
2012-06-05
First Submit QC Date:
None
Study First Post Date:
2012-06-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-01-31
Results First Submit QC Date:
None
Results First Post Date:
2015-02-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-11-07
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-01-31
Last Update Post Date:
2015-02-12
Last Update Post Date Type:
ESTIMATED